At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 43 enrolled
Drug / intervention
Hypochlorous acid solution 106 mg/L +2 moredrug
Likely dose
Hypochlorous acid solution 106 mg/Lfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase 1 21-Day Evaluation of the Cumulative Irritation Potential of RUT058-60 on Abraded and Non-Abraded Skin Sites
In Brief
A Phase 1 clinical trial evaluating Hypochlorous acid solution 106 mg/L, 0.1% (w/v) Sodium Lauryl Sulfate, and 1 other intervention for Irritation/Irritant. Completed, enrolled 43 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the skin irritation potential of RUT058-60 after repetitive patch application to abraded and non-abraded skin of human subjects.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIrritation/Irritant
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJul 2014
First PostedJul 2014
Primary CompletionAug 2014
Study CompletionSep 2014
TodayJul 2026
First PostedJul 24, 2014
Enrollment StartJul 1, 2014
Primary CompletionAug 1, 2014
Study CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 11.9 years ago
Interventions
Hypochlorous acid solution 106 mg/Ldrug
test product
0.1% (w/v) Sodium Lauryl Sulfatedrug
positive control
0.9% Physiological Saline, USPdrug
negative control